RESULTS: Patients with PAD who undergo lower extremity bypass warrant a comprehensive approach to risk factor modification for both primary and secondary prevention of cardiovascular and limb-related complications. This includes appropriate use of high-intensity statins, smoking cessation, and management of hypertension and diabetes. Additionally, antiplatelet therapy is indicated for all patients with CLTI and additional treatment with low-dose anticoagulation may also be beneficial.
CONCLUSIONS: Optimal medical therapy is essential for optimizing outcomes in patients with PAD undergoing lower extremity bypass.
结果:接受下肢搭桥手术的PAD患者需要采取全面的方法来改变危险因素,以进行心血管和肢体相关并发症的一级和二级预防。这包括适当使用高强度他汀类药物,戒烟,以及高血压和糖尿病的管理。此外,抗血小板治疗适用于所有CLTI患者,低剂量抗凝治疗也可能有益.
结论:最佳药物治疗对于优化下肢旁路手术患者的预后至关重要。